EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease

Chiara Venegoni iD, Silvia Tortorella iD, Alessandra Caliendo iD, Irene Locatelli iD, Alessia Di Coste iD, Erica Locatelli iD, Filippo Capancioni iD, Emanuela Bua iD, Simona Camorani iD, Andrea Salonia iD, Francesco Montorsi iD, Jithin Jose iD und 4 weitere

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202403314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Chiara Venegoni und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Experimental Oncology/Unit of Urology, URI, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Gold, Aptamers, Nucleotide, Nanotubes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, HORIZON EUROPE European Innovation Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limitations of current diagnostic imaging techniques and therapies for bladder cancer are associated with and responsible for the recurrence and progression of residual disease, with an impact on social costs and quality of life of patients. This study delivers a cost‐effective solution for the detection of bladder cancer residual disease, which is represented by the early detection of bladder cancer lesions < 1 mm. Urine‐stable 34‐mer SH‐terminated 2′F‐Py‐RNA aptamer that recognizes the integrin α5β1, expressed by 81% of human high‐grade non‐muscle invasive bladder cancer, is developed. The intravesical instillation of aptamer‐conjugated gold nanorods as contrast agent for photoacoustic imaging is validated in a preclinical model of orthotopic bladder cancer expressing the integrin α5β1. The photoacoustic signal of gold nanorods remains on the tumor surface for 3 h and allows early detection of cancer lesions < 1 mm. The aptamer is internalized into lysosomes, an opportunity that paves the way for lysosomal‐mediated drug release in tumor cells. This study highlights the potential of urine‐stable aptamer for the delivery of a solution to target the residual high‐grade bladder cancer disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsGoldAptamers, NucleotideNanotubesNeoplasm, ResidualEarly Detection of CancerHumansAnimalsMiceCell Line, Tumor

Stichwörter der Autor:innen

aptamerbladder cancerdetectionnanoparticlesurine

Substanzen

GoldAptamers, Nucleotide

Autor:innen und Institutionen

  • Division of Experimental Oncology/Unit of Urology, URI, IRCCS San Raffaele Scientific Institute, Milan, 20132, Italy.
  • Department of Industrial Chemistry "Toso Montanari", University of Bologna, Via P. Gobetti 85, Bologna, 40129, Italy.
  • Institute of Experimental Endocrinology and Oncology "Gaetano Salvatore", National Research Council, Naples, 80131, Italy.
  • Università Vita-Salute San Raffaele, Milan, 20132, Italy.
  • FUJIFILM Visualsonics Inc., Amsterdam, 1114 AB, The Netherlands.

ORCID-Profile: Chiara Venegoni, Silvia Tortorella, Alessandra Caliendo, Irene Locatelli, Alessia Di Coste, Erica Locatelli, Filippo Capancioni, Emanuela Bua, Simona Camorani, Andrea Salonia, Francesco Montorsi, Jithin Jose, Marco Moschini, Laura Cerchia, Mauro Comes Franchini, Massimo Alfano

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • HORIZON EUROPE European Innovation Council

Zitieren

APA

Venegoni, C., Tortorella, S., Caliendo, A., Locatelli, I., Coste, A. D., Locatelli, E., Capancioni, F., Bua, E., Camorani, S., Salonia, A., Montorsi, F., Jose, J., Moschini, M., Cerchia, L., Franchini, M. C., & Alfano, M. (2025). Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403314

Vancouver

Venegoni C, Tortorella S, Caliendo A, Locatelli I, Coste AD, Locatelli E, et al. Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403314

BibTeX
@article{Venegoni2025,
  author = {Venegoni, Chiara and Tortorella, Silvia and Caliendo, Alessandra and Locatelli, Irene and Coste, Alessia Di and Locatelli, Erica and Capancioni, Filippo and Bua, Emanuela and Camorani, Simona and Salonia, Andrea and Montorsi, Francesco and Jose, Jithin and Moschini, Marco and Cerchia, Laura and Franchini, Mauro Comes and Alfano, Massimo},
  title = {Urine‐Stable Aptamer‐Conjugated Gold Nanorods for the Early Detection of High‐Grade Bladder Cancer Residual Disease},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202403314}
}
Kostenlos starten →